I may be completely wrong but It wouldn’t surprise me if they have managed timing of likely garadacimab approval announcement to coincide with csl112 results release. That way any mixed news on csl112 will be obscured by the good news on garadacimab.
all around results release date late Feb.
Garadacimab and csl112
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$273.30 |
Change
-5.150(1.85%) |
Mkt cap ! $132.0B | |||
| Open | High | Low | Value | Volume |
| $275.10 | $275.24 | $272.37 | $199.1M | 726.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 200 | $273.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $273.34 | 12 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$273.21 |
Change
-5.150 ( 1.93 %) |
||||
| Open | High | Low | Volume | ||
| $275.24 | $275.24 | $272.38 | 30785 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| CSL (ASX) Chart |